Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-21

Clinical Trial Update: ED90 of Remimazolam Loading Dose for Sedation in Patients Under Monitored Anesthetic Care [Phase 4]

View source ↗

Summary

Phase 4 clinical trial updating the ED90 loading dose of remimazolam for sedation in monitored anesthesia care.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Remimazolam (remimazolam)

Snippet

Sponsor: Asan Medical Center | Conditions: Remimazolam, Orthopedic Procedures | Phase 4 | Status: COMPLETED